Position in NBP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,419,321
-$569,035 QoQ
Shares Held
576,960
+15.5% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Exome Asset Management LLC holds $121,183,293 across 31 Biotechnology names. NBP ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
45,469 | $14,649,657 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
278,533 | $10,720,735 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
220,091 | $8,627,567 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
110,064 | $8,264,705 | |
| 5 | CYTK |
Cytokinetics Inc
|
103,718 | $6,836,053 | |
| 6 | ALMS |
Alumis Inc.
|
279,176 | $6,150,247 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
67,492 | $5,011,955 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
114,991 | $4,626,087 |
All Filings in NBP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,419,321 | 576,960 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,988,356 | 499,587 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,441,703 | 1,439,604 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $453,238 | 271,400 | Shares | Sole | 2024-10-03 | |
| 2024-03-31 | $605,917 | 325,762 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||